Ahrensburg, Germany

Velocity Clinical Research Germany GmbH

Founded in 1999 as The Pulmonary Research Institute at the LungenClinic Grosshansdorf and acquired by Velocity Clinical Research in 2024, the experienced team at Velocity’s dedicated research site in Ahrensburg conducts clinical trials across a broad variety of indications, and specializes in pulmonary diseases. By developing strong working relationships with local communities and a robust patient database, Velocity’s Ahrensburg staff provides fast, accurate patient enrollment support, even for diverse populations.

Our Ahrensburg team is committed to being a resource for study volunteers, to providing the highest quality of patient care with compassion and kindness and to advancing medicine through research.

Now Enroling in Ahrensburg

Velocity is enroling participants for clinical trials in Ahrensburg for the following conditions:

  • Asthma
  • COPD
  • Bronchiectasis
  • Idiopathic pulmonary fibrosis and other interstitial lung diseases

Velocity Clinical Research Germany GmbH
Klaus-Groth-Strasse 2-4, 2. Etage, Ahrensburg, Germany 22926

Phone: 0049-4102-8881-0

Find a Clinical Trial in Ahrensburg
Call today to speak with an enrolment specialist about available research studies in Ahrensburg.

Portrait Of Medical Team Standing Outside Hospital

About Velocity Clinical Research

140,000+ people have a joined a study at Velocity

Many people enjoy the study experience and have joined several clinical trials at Velocity.

Velocity has decades of research experience

With sites that were established as long ago as 1986, Velocity has experts who have supported clinical trials for decades.

Velocity studies are led by healthcare professionals

All clinical trials conducted at Velocity are overseen by licensed healthcare professionals.

Our experienced research team in Ahrensburg

Every clinical trial is overseen by a Principal Investigator – a physician who is responsible for the rights, safety and welfare of the study participants. Our clinical research team in Ahrensburg is dedicated to conducting quality research in a professional and caring environment.

  • Henrick Watz

    Henrik Watz, MD

    Medical Director, Principal Investigator
    Prior to joining Velocity, Dr. Watz co-led the Pulmonary Research Institute at the LungeClinic Grosshansdorf (PRI) since 2007. Under his lead, along with his colleague, Dr. Kirsten, PRI conducted over 300 studies, as well as contributed to more than 250 publications and over 300 conferences since then. Dr. Watz is a pulmonologist and internist with experience in many pulmonology indications, including COPD, bronchial asthma, bronchiectasis and pulmonary fibrosis, sarcoidosis, lymphangioleiomyomatosis, and pulmonary hypertension in fibrosing lung diseases.

  • Anne-Marie Kirsten

    Anne-Marie Kirsten, MD

    Principal Investigator, Site Director
    Prior to joining Velocity, Dr. Kirsten co-led the Pulmonary Research Institute at the LungeClinic Grosshansdorf (PRI) since 2007. Under her lead, along with her colleague, Dr. Watz, PRI conducted over 300 studies, as well as contributed to more than 250 publications and over 300 conferences since then. Dr. Kirsten is a pulmonologist and internist with experience in many pulmonology indications, including COPD, bronchial asthma, bronchiectasis and pulmonary fibrosis, sarcoidosis, lymphangioleiomyomatosis, and pulmonary hypertension in fibrosing lung diseases.

Call today to start your clinical trial journey in Ahrensburg

Beyond helping advance medicine, you may also:

  • Learn about potential new medicines in development
  • Get study-related medical exams at no cost
  • Receive reimbursement for participating

After you submit your info, a Velocity staff member will review your info. They will contact you to discuss the study, or others that may be suitable for you.

Remember, there is never an obligation to join — we're here to help you make the best decision.

Submit your info

Contact information

Name(Required)
Address(Required)

Personal information

Date of Birth(Required)
Approximate age can help us determine study eligibility (you must be age 18 or older to submit this form).
This field is hidden when viewing the form
Race
Select one or more designations that best describe you. This information can help Velocity better ensure all populations are represented in research.

Data use and declaration of consent

Data protection: The protection of your personal data and privacy is particularly important to us. Please note our privacy notice for patient database. By submitting this form, I agree to the use of my data in accordance with the privacy notice for patient database, in particular regarding smoking status, height, and weight.

Personal information: In order to check whether you are generally suitable for taking part in this study, the preceding voluntary information will help us. By submitting this form, I hereby confirm that the data I have entered may be used to check whether I am fundamentally suitable to take part in this study.

Declaration of consent: After receiving your data, we will contact you by telephone or email to check and discuss your suitability for participation in this study. By submitting this form, I hereby give my revocable consent to the inclusion of my personal data in the patient database. I further agree that Velocity Clinical Research's legal entities may contact me by telephone or email to determine my suitability to participate in this to check the study and discuss it with me. In the event that I am considered as a patient, my data will be stored and processed by Velocity Clinical Research and/or its legal entities (view Velocity's legal entities).

We will inform you about new studies

This field is hidden when viewing the form
This field is for validation purposes and should be left unchanged.

Sponsors and CROs

From the leading pharma companies, to the most pioneering biotech startups, Velocity supports those who are exploring new frontiers in human health. Whether you’re ready to conduct a single-site study or a complex, high-volume clinical trial, trust Velocity.

clinical research team

It all starts with people like you.

Without clinical trial participants, it would not be possible to create new medicines, treatments, and cures.